A Randomized Comparison of One Controlled Ovarian Stimulation With Corifollitropin Alfa Versus up to Three Modified Natural Cycles in Expected and Established Poor Responders
Latest Information Update: 01 Jul 2024
At a glance
- Drugs Corifollitropin alfa (Primary)
- Indications Female infertility; Ovulation disorders
- Focus Therapeutic Use
- Acronyms MONACO
- 19 Dec 2023 Planned number of patients changed from 208 to 300.
- 25 Mar 2022 Status changed from not yet recruiting to recruiting.
- 24 Jan 2022 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.